Advocacy intelligence hub — real-time data for patient organizations
Qingyuan Zhan — PHASE3
DiaSorin Molecular LLC — NA
The University of Texas Health Science Center, Houston — NA
Cellenkos, Inc. — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
David L Paterson, MD, md
University of Pittsburgh/University of Pittsburgh Medical Center
📍 PITTSBURGH, PA
Alia Warner, Ph.D.
The University of Texas Health Science Center at Houston
📍 Houston, Texas
Tapan M Kadia, MD
Sarcoma Oncology Research Center, Cancer Center of Southern California
📍 Santa Monica, California